We are live on ! Find out more
AV

ASR Vermogensbeheer Portfolio holdings

AUM $8.5B
1-Year Est. Return 25.14%
This Fund
S&P 500
This Quarter Est. Return
-3.12%
1 Year Est. Return
+25.14%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$8.5B
AUM Growth
-$96.1M
Cap. Flow
+$411M
Cap. Flow %
4.83%
Top 10 Hldgs %
34.38%
Holding
534
New
8
Increased
456
Reduced
39
Closed
2

Top Buys

1
AZN icon
AstraZeneca
AZN
+$162M
2
SUNB
Sunbelt Rentals Holdings
SUNB
+$41.2M
3
NVDA icon
NVIDIA
NVDA
+$33.2M
4
UBS icon
UBS Group
UBS
+$19.4M
5
AAPL icon
Apple
AAPL
+$16.9M

Top Sells

1
META icon
Meta Platforms (Facebook)
META
+$17.1M
2
BDX icon
Becton Dickinson
BDX
+$8.94M
3
SLB icon
SLB Ltd
SLB
+$7.67M
4
GIB icon
CGI
GIB
+$4.75M
5
AMAT icon
Applied Materials
AMAT
+$3.24M

Sector Composition

1 Technology 30.92%
2 Financials 13.2%
3 Healthcare 11.8%
4 Consumer Discretionary 10.12%
5 Communication Services 10.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BMY icon
126
Bristol-Myers Squibb
BMY
$124B
$14.4M 0.17%
236,859
+4,490
+2% +$262K
RACE icon
127
Ferrari
RACE
$66.3B
$14.3M 0.17%
42,875
-1,377
-3% -$482K
MMM icon
128
3M
MMM
$83.4B
$14.2M 0.17%
97,986
+1,560
+2% +$248K
ITW icon
129
Illinois Tool Works
ITW
$79.4B
$14.2M 0.17%
54,505
+1,530
+3% +$416K
ADI icon
130
Analog Devices
ADI
$183B
$14M 0.16%
43,908
+705
+2% +$224K
ES icon
131
Eversource Energy
ES
$28.1B
$13.6M 0.16%
196,671
+4,206
+2% +$297K
EXC icon
132
Exelon
EXC
$47.3B
$13.6M 0.16%
276,921
+4,688
+2% +$218K
BLK icon
133
Blackrock
BLK
$166B
$13.6M 0.16%
14,096
+706
+5% +$743K
MDT icon
134
Medtronic
MDT
$106B
$13.6M 0.16%
156,403
+3,471
+2% +$333K
EQIX icon
135
Equinix
EQIX
$101B
$13.5M 0.16%
13,821
+252
+2% +$224K
ADM icon
136
Archer Daniels Midland
ADM
$41.4B
$13.1M 0.15%
180,533
+2,900
+2% +$196K
UNP icon
137
Union Pacific
UNP
$179B
$13.1M 0.15%
54,003
+972
+2% +$238K
FER icon
138
Ferrovial N.V. Ordinary Shares
FER
$45.5B
$13.1M 0.15%
206,397
-29,712
-13% -$2M
GWW icon
139
W.W. Grainger
GWW
$65.9B
$12.9M 0.15%
11,850
+223
+2% +$244K
SHW icon
140
Sherwin-Williams
SHW
$81.7B
$12.8M 0.15%
40,052
+732
+2% +$252K
KR icon
141
Kroger
KR
$36B
$12.7M 0.15%
175,074
+2,980
+2% +$202K
QCOM icon
142
Qualcomm
QCOM
$181B
$12.5M 0.15%
96,940
+1,807
+2% +$264K
TRV icon
143
Travelers Companies
TRV
$78.5B
$12.4M 0.15%
42,615
+790
+2% +$231K
HLT icon
144
Hilton Worldwide
HLT
$73.1B
$12.2M 0.14%
40,225
+677
+2% +$205K
EIX icon
145
Edison International
EIX
$29.9B
$12.1M 0.14%
165,749
+3,242
+2% +$219K
BEPC icon
146
Brookfield Renewable
BEPC
$6.18B
$12M 0.14%
301,341
-20,978
-7% -$855K
CAH icon
147
Cardinal Health
CAH
$53.5B
$12M 0.14%
56,616
-1,447
-2% -$312K
VRTX icon
148
Vertex Pharmaceuticals
VRTX
$123B
$11.9M 0.14%
26,691
+632
+2% +$295K
ADP icon
149
Automatic Data Processing
ADP
$102B
$11.7M 0.14%
57,528
+1,001
+2% +$230K
PANW icon
150
Palo Alto Networks
PANW
$292B
$11.6M 0.14%
72,667
+3,440
+5% +$578K
4 5
6
7 8

Similar funds

GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NB
Norinchukin Bank Tokyo, Japan $8.57B AUM 20.17% 1-Year Est. Return
ACM
Advisors Capital Management Ridgewood, New Jersey $8.58B AUM 23.43% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return

ASR Vermogensbeheer's Q1 2026 Portfolio in Review

As of Q1 2026, ASR Vermogensbeheer held 534 positions worth $8.5B, down 1.1% from $8.6B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

ASR Vermogensbeheer deployed $411M of net new capital in Q1 2026, opening 8 new positions and adding to 456 existing holdings. Its largest new stake was AstraZeneca: 841,921 shares worth $163M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 33% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $17.1M trimmed.

  • ASR Vermogensbeheer's largest Q1 2026 buy was AstraZeneca: 841,921 shares worth $163M.
  • ASR Vermogensbeheer added most to NVIDIA in Q1 2026, an estimated $33.2M increase.
  • ASR Vermogensbeheer's biggest Q1 2026 reduction was Meta Platforms (Facebook), cutting an estimated $17.1M.
  • ASR Vermogensbeheer fully exited Amrize Ltd in Q1 2026, selling an estimated $1.58M.
  • ASR Vermogensbeheer's ten largest holdings make up 34% of its $8.5B portfolio in Q1 2026.
  • ASR Vermogensbeheer opened 8 new positions and closed 2 in Q1 2026.
  • ASR Vermogensbeheer's portfolio value fell 1.1% quarter-over-quarter to $8.5B.

Based on ASR Vermogensbeheer's 13F filing for Q1 2026, filed 30 Apr 2026.